- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,433GBP
- Report
- August 2026
- 384 Pages
Global
From €5232EUR$5,850USD£4,473GBP
- Report
- August 2026
- 455 Pages
Global
From €5232EUR$5,850USD£4,473GBP
- Report
- August 2026
- 202 Pages
Global
From €5232EUR$5,850USD£4,473GBP
- Report
- August 2026
- 173 Pages
Global
From €5232EUR$5,850USD£4,473GBP
- Report
- August 2026
- 451 Pages
Global
From €5232EUR$5,850USD£4,473GBP
- Report
- August 2026
- 283 Pages
Global
From €5232EUR$5,850USD£4,473GBP
- Report
- August 2026
- 424 Pages
Global
From €5232EUR$5,850USD£4,473GBP
- Report
- May 2026
- 150 Pages
Global
From €3354EUR$3,750USD£2,867GBP
- Report
- July 2026
- 120 Pages
Global
From €4248EUR$4,750USD£3,632GBP
- Report
- April 2026
- 111 Pages
Global
From €4248EUR$4,750USD£3,632GBP
- Report
- January 2026
- 147 Pages
Global
From €3533EUR$3,950USD£3,020GBP
- Report
- August 2025
- 145 Pages
Global
From €3533EUR$3,950USD£3,020GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more